Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers
A review, which included licensed drugs lecanemab and donanemab, found the effects were ‘trivial’.
Alzheimer's Drugs Benefits Labeled 'Trivial'
- Dementia drugs hailed as 'beginning of the end' for Alzheimer's do not work, major report finds Daily Mail —
- Alzheimer's drugs make 'no meaningful difference' RTE —
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC News —
- Much-hyped Alzheimer’s drugs do not help patients, review finds The Straits Times —
- Alzheimer’s drugs ‘make no meaningful difference to patients,’ major review suggests The Independent —